Hrt Financial LP Revance Therapeutics, Inc. Transaction History

Hrt Financial LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$11.47 - $25.07 $68 - $150	6 Added 0.04%	14,364 $164,000
Q2 2023 Aug 11, 2023	BUY	$24.7 - $37.61 $354,642 - $540,004	14,358 New	14,358 $363,000
Q1 2021 May 17, 2021	SELL	$24.03 - $29.97 $203,846 - $254,235	-8,483 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$23.41 - $28.34 $198,587 - $240,408	8,483 New	8,483 $240,000

208

80.9M

2.26M

5.48M

Ticker RVNC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,305,696
Market Cap $212M
Description
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.